IPO registrations (S-1, F-1) · Registrants
ALBANY MOLECULAR RESEARCH INC
- SEC CIK
- 1065087 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 1998-07-09, last 1999-02-02; 1 initial registration, 5 amendments
- Outcome
- Final prospectus filed 1999-02-05
- Industry (SIC)
- Services-Commercial Physical & Biological Research 8731
- Incorporated in
- DE
- Business address
- 21 CORPORATE CIRCLE, P O BOX 15098, Albany, NY 12203-5154
- EIN
- 14-1742717
- EDGAR entity type
- operating
- Insiders and CEO pay
- ALBANY MOLECULAR RESEARCH INC on the corporate pages
Offering terms
- Proposed price range
- $17.00–$19.00 per share (S-1/A filed 1999-02-02)
- Final price
- $2.47 per share, below the range (424B4 filed 1999-02-05, an initial public offering)
- Shares sold
- 2,500,000
- Gross proceeds
- $6,175,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol AMRI
- Lead underwriters
- ING; Hambrecht & Quist (742,500 shares)
- Syndicate
- Robertson Stephens (70,000); Bear Stearns (70,000); BT Alex. Brown (70,000); Oppenheimer (70,000); EVEREN Securities, Inc (70,000); Lehman Brothers (70,000); Morgan Stanley (70,000); Montgomery Securities (70,000); Cowen (70,000); UBS (70,000); William Blair (35,000); RBC Capital Markets (35,000); Dominick & Dominick LLC (35,000); First Albany Corporation (35,000); Interstate/Johnson Lane Corporation (35,000); C.L. King & Associates (35,000); Pacific Growth Equities, Inc (35,000); Pennsylvania Merchant Group Ltd (35,000); Piper Sandler (35,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: CURIA GLOBAL INC. EXACT (EIN (EXACT))
- SEC filer: ALBANY MOLECULAR RESEARCH INC EXACT (CIK (EXACT))
- Person page: Mark T Frost Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))
- Person page: Una S Ryan Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 9
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1998-07-09 | S-1 | S-1 (registration) | ALBANY MOLECULAR RESEARCH INC | 0000927016-98-002632 ↗ |
| 1998-07-15 | S-1/A | S-1/A (amendment) | ALBANY MOLECULAR RESEARCH INC | 0000927016-98-002666 ↗ |
| 1998-08-14 | S-1/A | S-1/A (amendment) | ALBANY MOLECULAR RESEARCH INC | 0000927016-98-003147 ↗ |
| 1998-12-08 | S-1/A | S-1/A (amendment) | ALBANY MOLECULAR RESEARCH INC | 0000927016-98-004196 ↗ |
| 1999-01-07 | S-1/A | S-1/A (amendment) | ALBANY MOLECULAR RESEARCH INC | 0000927016-99-000023 ↗ |
| 1999-02-02 | S-1/A | S-1/A (amendment) | ALBANY MOLECULAR RESEARCH INC | 0000927016-99-000260 ↗ |
| 1999-02-05 | S-1MEF | S-1MEF (added securities) | ALBANY MOLECULAR RESEARCH INC | 0000927016-99-000309 ↗ |
| 1999-02-05 | 424B4 | 424B4 (final prospectus) | ALBANY MOLECULAR RESEARCH INC | 0000927016-99-000310 ↗ |
| 2000-10-06 | 424B4 | 424B4 (final prospectus) | ALBANY MOLECULAR RESEARCH INC | 0000912057-00-044092 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 1999-02-02 | S-1/A | registration statement | $17.00–$19.00 | 2,200,000 | - | Nasdaq AMRI | 2 | from the submission text; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 2 | document ↗ | |
| 1999-02-05 | 424B4 | final prospectus | $2.47 | 2,500,000 | $6,175,000 | Nasdaq AMRI | 21 | from the submission text; price line, shares headline, proceeds computed, underwriting table 20, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| ANDERSON PAUL S | Director | 10 | 2006–2011 | ||
| KUHLA DONALD E | Director; Director,Officer | Executive Vice President | 7 | 2006–2008 | |
| OCONNOR KEVIN | Director | 26 | 2006–2017 | ||
| ROTH ARTHUR J | Director | 24 | 2006–2017 | ||
| TARTAGLIA ANTHONY P | Director | 9 | 2006–2009 | ||
| Frost Mark T | Officer | Chief Financial Officer | 12 | 2006–2012 | person page Fuzzy |
| Shultis Kenton L | Officer | VP and GM, Organichem | 1 | 2006 | |
| TROVA MICHAEL P | Officer | Sr. VP, Chemistry | 1 | 2006 | |
| HAYDU FRANK | Director | 1 | 2006 | ||
| RYAN UNA S | Director | 24 | 2006–2017 | person page Fuzzy | |
| D AMBRA CONSTANCE M | TenPercentOwner | 32 | 2006–2016 | ||
| D AMBRA THOMAS E | Director; Director,Officer,TenPercentOwner; DirectorOther | Chairman, Board of Directors; Chairman, CEO & President | 51 | 2006–2017 | |
| Jordan Veronica GH | Director | 20 | 2006–2016 | ||
| Evans Johnathan D | Officer | VP Pharma Dev & Manu | 3 | 2007 | |
| JENNINGS WILLIAM STEVEN | Officer | Senior Vice President | 3 | 2008–2010 | |
| Hagen Steven R | Officer | Sr VP Pharmaceutical Dev & Mfg; SVP Manufacturing & Pharmaceut; SVP Pharmaceutical Dev & Mfg; VP Pharmaceutical Dev & Mfg | 89 | 2008–2017 | |
| LEUNG GABRIEL | Director | 10 | 2010–2015 | ||
| HENDERSON LORI M | Officer | SVP, Secretary & Gen Counsel; SVP, Secretary & Gen. Counsel; VP, general counsel; VP, Secretary & Gen. Counsel | 37 | 2011–2017 | |
| Sargent Bruce J | Officer | Sr VP, Drug Discovery | 15 | 2011–2013 | |
| CABLE STUART M | TenPercentOwner | 28 | 2011–2015 | ||
| Marth William S | Director; Director,Officer | President and CEO | 30 | 2012–2017 | |
| Nolan Michael M | Officer | CFO; SVP, CFO and Treasurer; VP, CFO and Treasurer | 11 | 2012–2015 | |
| DAmbra Geoffrey | TenPercentOwner | 1 | 2013 | ||
| THOMAS DAMBRA SLAT TRUST | TenPercentOwner | 1 | 2013 | ||
| Luther Michael A | Officer | Senior VP, Discovery Services; Senior VP. Discovery Services | 4 | 2013–2015 | |
| Svokos George | Officer | Chief Commercial Officer; Chief Operating Officer; Sr. VP Sales & GM of API; SVP Sales & GM of API | 22 | 2014–2017 | |
| Ladin Felicia I | Officer | CFO; SVP & Treasurer; SVP, Treasurer & CFO | 11 | 2015–2017 | |
| Gutierrez Fuentes Luis Gerardo | Director | 5 | 2015–2017 | ||
| D'Ambra David | TenPercentOwner | 2 | 2015–2016 | ||
| MADDALUNA ANTHONY J | Director | 6 | 2016–2017 | ||
| Deming David H | Director | 4 | 2016–2017 | ||
| HAGEN KENNETH PAUL | Director | 4 | 2016–2017 | ||
| NAPOLITANO FERNANDO | Director | 3 | 2016–2017 | ||
| Clessidra S.G.R. S.p.A. | Other | 1 | 2016 | ||
| Lauro Cinquantasette S.p.A. | Director,TenPercentOwner | 1 | 2016 | ||
| Lauro Quarantotto S.p.A. | Other | 1 | 2016 | ||
| Mandarin Capital Management Secondary SA | Other | 1 | 2016 | ||
| Mandarin Capital Partners Secondary SCA SICAR | Other | 1 | 2016 | ||
| BOYER MILTON | Officer | SVP, Drug Product Manufacturin; SVP Drug Product Manufacturing | 7 | 2016–2017 | |
| CONWAY CHRISTOPHER M. | Officer | SVP, Discovery and Development | 6 | 2016–2017 | |
| FINE MARGALIT | Officer | Executive Vice President, API | 4 | 2016–2017 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | CURIA GLOBAL, INC. | NY | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Patent assignee | ALBANY MOLECULAR RESEARCH, INC. | NY | Patents (USPTO) | name and state |
| SEC filer | ALBANY MOLECULAR RESEARCH INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Albany Molecular Research, Inc. | NY | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | CURIA GLOBAL INC. | EIN (EXACT) | ||
| Person page | Mark T Frost | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer) | |
| Person page | Una S Ryan | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Commercial Physical & Biological Research, NY first:
- NanoDynamics, Inc. NY
- Optimus Healthcare Services, Inc. NY
- COMBICHEM INC CA
- AURORA BIOSCIENCES CORP CA
- DGI RESOLUTION INC K6
- PRA INTERNATIONAL INC VA
- QUEST DIAGNOSTICS INVESTMENTS INC NJ
- SIGNAL PHARMACEUTICALS INC CA
- CURAGEN CORP MA
- DELTAGEN INC CA
In other datasets, the same topic (Medical research) in NY:
- Nonprofit: 360 WHITEHALL HOUSING DEVELOPMENT FUND CORP (Nonprofits (IRS Form 990))
Interests: Services-Commercial Physical & Biological Research · Medical research